These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10990126)
1. Efficacy and practicability of inhaled nitric oxide and aerosolized prostaglandins. Booke M; Hinder F Intensive Care Med; 2000 Jul; 26(7):1015-6. PubMed ID: 10990126 [No Abstract] [Full Text] [Related]
2. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin. Tibballs J; Goh TH; McKenzie I; Hochmann M Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572 [No Abstract] [Full Text] [Related]
3. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin. Barry PW Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434 [No Abstract] [Full Text] [Related]
4. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166 [TBL] [Abstract][Full Text] [Related]
11. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651 [TBL] [Abstract][Full Text] [Related]
12. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension. Max M; Kuhlen R; Dembinski R; Rossaint R Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974 [TBL] [Abstract][Full Text] [Related]
13. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation? Eichelbrönner O; Reinelt H; Wiedeck H; Mezödy M; Rossaint R; Georgieff M; Radermacher P Intensive Care Med; 1996 Sep; 22(9):880-7. PubMed ID: 8905421 [TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Putensen C; Hörmann C; Kleinsasser A; Putensen-Himmer G Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1743-7. PubMed ID: 9620900 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin. Rocca GD; Coccia C; Pompei L; Ruberto F; Venuta F; De Giacomo T; Pietropaoli P J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):224-7. PubMed ID: 11312484 [TBL] [Abstract][Full Text] [Related]
16. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720 [TBL] [Abstract][Full Text] [Related]
17. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study. Van Heerden PV; Blythe D; Webb SA Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance. Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041 [TBL] [Abstract][Full Text] [Related]